The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cysteine market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Cysteine is a non-essential sulfur-based amino acid used for protein synthesis, detoxification and numerous metabolic functions. It is biosynthesized through beta-keratin in nails, skin and hair and it promotes the stability of proteins by building di-sulfide bridges. It also increases collagen production and improves skin elasticity and texture. It is a rich source of antioxidants and aids in reducing inflammation, cell damage and reversing the effects of aging. Cysteine metabolizes essential biochemicals, such as coenzyme A, heparin and biotin and can also aid in minimizing the risks of developing cancer, diabetes and cardiovascular ailments. As a result, it is widely used as a reducing agent in the manufacturing of pharmaceuticals, cosmetics, personal care products, food supplements and flavor enhancers.
Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Cysteine is widely used for total parenteral nutrition and as an antidote for acetaminophen overdose. It also aids in the treatment of metabolic disorders and malabsorption syndromes. Moreover, the widespread product adoption in the food and beverage industry is providing a thrust to the market growth. Cysteine is used as a dough conditioner and strengthener to break the disulfide bonds of gluten and lower the viscosity of the dough in bakery products. In line with this, the increasing product utilization in the manufacturing of cosmetics and personal care products is also contributing to the market growth. Cysteine acts as an anti-static, conditioning and waving agent and fragrance ingredient in hair care products. Other factors, including extensive research and development (R&D) activities, along with the increasing expenditure capacities of the consumers, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cysteine market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on production process, application and end use industry.
Breakup by Production Process:
Breakup by Application:
Breakup by End Use Industry:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Co. Inc., CJ CheilJedang Corp., Merck KGaA, Nippon Rika Co. Ltd, Shanghai Cosroma Biotech Co. Ltd, Shine Star (Hubei) Biological Engineering Co. Ltd., Wacker Chemie AG, Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.) and Wuxi Bikang Bioengineering Co. Ltd.
|Base Year of the Analysis||2020|
|Segment Coverage||Production Process, Application, End Use Industry, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Ajinomoto Co. Inc., CJ CheilJedang Corp., Merck KGaA, Nippon Rika Co. Ltd, Shanghai Cosroma Biotech Co. Ltd, Shine Star (Hubei) Biological Engineering Co. Ltd., Wacker Chemie AG, Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.) and Wuxi Bikang Bioengineering Co. Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at